186 related articles for article (PubMed ID: 22619053)
1. Correlates of tumor development in patients with myotonic dystrophy.
Das M; Moxley RT; Hilbert JE; Martens WB; Letren L; Greene MH; Gadalla SM
J Neurol; 2012 Oct; 259(10):2161-6. PubMed ID: 22619053
[TBL] [Abstract][Full Text] [Related]
2. Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM Registries.
Higgs C; Hilbert JE; Wood L; Martens WB; Marini-Bettolo C; Nikolenko N; Alsaggaf R; Lochmüller H; Moxley RT; Greene MH; Wang Y; Gadalla SM
Front Neurol; 2019; 10():1071. PubMed ID: 31681146
[No Abstract] [Full Text] [Related]
3. Pigmentation phenotype, photosensitivity and skin neoplasms in patients with myotonic dystrophy.
Gadalla SM; Hilbert JE; Martens WB; Givens S; Moxley RT; Greene MH
Eur J Neurol; 2017 May; 24(5):713-718. PubMed ID: 28317292
[TBL] [Abstract][Full Text] [Related]
4. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
Fitzgerald BP; Conn KM; Smith J; Walker A; Parkhill AL; Hilbert JE; Luebbe EA; Moxley RT
J Neurol; 2016 Dec; 263(12):2528-2537. PubMed ID: 27734165
[TBL] [Abstract][Full Text] [Related]
5. Frequency and type of cancers in myotonic dystrophy: A retrospective cross-sectional study.
D'Ambrosio ES; Chuang K; David WS; Amato AA; Gonzalez-Perez P
Muscle Nerve; 2023 Aug; 68(2):142-148. PubMed ID: 36790141
[TBL] [Abstract][Full Text] [Related]
6. Cardiac involvement in myotonic dystrophy: a nationwide cohort study.
Lund M; Diaz LJ; Ranthe MF; Petri H; Duno M; Juncker I; Eiberg H; Vissing J; Bundgaard H; Wohlfahrt J; Melbye M
Eur Heart J; 2014 Aug; 35(32):2158-64. PubMed ID: 24742887
[TBL] [Abstract][Full Text] [Related]
7. Benign tumors in myotonic dystrophy type I target disease-related cancer sites.
Alsaggaf R; St George DMM; Zhan M; Pfeiffer RM; Wang Y; Anderson LA; Liu Z; Koshiol J; Bauer AJ; Wagner KR; Greene MH; Amr S; Gadalla SM
Ann Clin Transl Neurol; 2019 Aug; 6(8):1510-1518. PubMed ID: 31402615
[TBL] [Abstract][Full Text] [Related]
8. Myotonic dystrophies.
Huang CC; Kuo HC
Chang Gung Med J; 2005 Aug; 28(8):517-26. PubMed ID: 16265841
[TBL] [Abstract][Full Text] [Related]
9. Supraventricular and Ventricular Arrhythmias Are Related to the Type of Myotonic Dystrophy but Not to Disease Duration or Neurological Status.
Bienias P; Łusakowska A; Ciurzyński M; Rymarczyk Z; Irzyk K; Kurnicka K; Kamińska A; Pruszczyk P
Pacing Clin Electrophysiol; 2016 Sep; 39(9):959-68. PubMed ID: 27444982
[TBL] [Abstract][Full Text] [Related]
10. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
Cho DH; Tapscott SJ
Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
[TBL] [Abstract][Full Text] [Related]
11. [Increasing risk of tumors in myotonic dystrophy type 1].
Mohamed S; Pruna L; Kaminsky P
Presse Med; 2013 Sep; 42(9 Pt 1):e281-4. PubMed ID: 23477718
[TBL] [Abstract][Full Text] [Related]
12. Diabetes, metformin and cancer risk in myotonic dystrophy type I.
Alsaggaf R; Pfeiffer RM; Wang Y; St George DMM; Zhan M; Wagner KR; Amr S; Greene MH; Gadalla SM
Int J Cancer; 2020 Aug; 147(3):785-792. PubMed ID: 31749144
[TBL] [Abstract][Full Text] [Related]
13. Peripheral nerve involvement in myotonic dystrophy type 2 - similar or different than in myotonic dystrophy type 1?
Nojszewska M; Łusakowska A; Szmidt-Salkowska E; Gaweł M; Lipowska M; Sułek A; Krysa W; Rajkiewicz M; Seroka A; Kaczmarek K; Kamińska AM
Neurol Neurochir Pol; 2015; 49(3):164-70. PubMed ID: 26048604
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic odyssey of patients with myotonic dystrophy.
Hilbert JE; Ashizawa T; Day JW; Luebbe EA; Martens WB; McDermott MP; Tawil R; Thornton CA; Moxley RT
J Neurol; 2013 Oct; 260(10):2497-504. PubMed ID: 23807151
[TBL] [Abstract][Full Text] [Related]
15. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
Meola G
Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
[TBL] [Abstract][Full Text] [Related]
16. Benign and malignant tumors in the UK myotonic dystrophy patient registry.
Alsaggaf R; Wang Y; Marini-Bettolo C; Wood L; Nikolenko N; Lochmüller H; Greene MH; Gadalla SM
Muscle Nerve; 2018 Feb; 57(2):316-320. PubMed ID: 28662292
[TBL] [Abstract][Full Text] [Related]
17. An Age-Standardized Prevalence Estimate and a Sex and Age Distribution of Myotonic Dystrophy Types 1 and 2 in the Rome Province, Italy.
Vanacore N; Rastelli E; Antonini G; Bianchi ML; Botta A; Bucci E; Casali C; Costanzi-Porrini S; Giacanelli M; Gibellini M; Modoni A; Novelli G; Pennisi EM; Petrucci A; Piantadosi C; Silvestri G; Terracciano C; Massa R
Neuroepidemiology; 2016; 46(3):191-7. PubMed ID: 26882032
[TBL] [Abstract][Full Text] [Related]
18. Utility and Results from a Patient-Reported Online Survey in Myotonic Dystrophies Types 1 and 2.
Wenninger S; Stahl K; Montagnese F; Schoser B
Eur Neurol; 2020; 83(5):523-533. PubMed ID: 33120389
[TBL] [Abstract][Full Text] [Related]
19. Clinical and genetic characteristics of childhood-onset myotonic dystrophy.
Stokes M; Varughese N; Iannaccone S; Castro D
Muscle Nerve; 2019 Dec; 60(6):732-738. PubMed ID: 31520483
[TBL] [Abstract][Full Text] [Related]
20. Risk of skin cancer among patients with myotonic dystrophy type 1 based on primary care physician data from the U.K. Clinical Practice Research Datalink.
Wang Y; Pfeiffer RM; Alsaggaf R; Meeraus W; Gage JC; Anderson LA; Bremer RC; Nikolenko N; Lochmuller H; Greene MH; Gadalla SM
Int J Cancer; 2018 Mar; 142(6):1174-1181. PubMed ID: 29114849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]